Drug Prior Authorization Committee Meeting Materials
Meeting information is retained on this page for 7 years then sent to the Missouri State Archives.
Register for Public Comment
Any interested party shall be granted the opportunity for clinically relevant public comment for up to three (3) minutes per medication under review by the DPAC. The responsibility of scheduling the presentation shall rest with the interested party, and registration must be completed prior to the scheduled meeting. Interested parties representing a manufacturer shall be granted three (3) minutes in the aggregate per medication under review by the DPAC.
2025
2024
2023
2025
April 15, 2025
- Pharmacy April 2025
- Edit Implementation Schedule For April 2025
- Old Business- ADHD, Amphetamines Long Acting PDL Edit April 2025
- Old Business- ADHD, Methylphenidate Long Acting PDL Edit April 2025
- Old Business- ADHD, Methylphenidate Short Acting PDL Edit
- PDL Recommendations April 2025
- PDL Announcements July 2025
- Conduent Reports April 2025
- New Drugs April 2025
DUR Criteria
Clinical and Fiscal Edits- Existing Criteria
Media
DUR Criteria
Clinical and Fiscal Edits- New or Revised of Existing Criteria
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
January 14, 2025
DUR Criteria
Clinical and Fiscal Edits- Existing Criteria
Media
DUR Criteria
Clinical and Fiscal Edits- New or Revised of Existing Criteria
Media
DUR Criteria
Resource List - New or Revised Criteria
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
2024
October 15, 2024
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
DUR Criteria
Clinical and Fiscal Edits- Existing Criteria
Media
DUR Criteria
Clinical and Fiscal Edits- New or Revised of Existing Criteria
Media
July 16, 2024
DUR Criteria
Clinical and Fiscal Edits- Existing Criteria
DUR Criteria
Clinical and Fiscal Edits- New or Revised of Existing Criteria
Media
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
April 16, 2024
DUR Criteria
Clinical Edit Proposals – Existing Criteria
DUR Criteria
Clinical and Fiscal Edits- New or Revised of Existing Criteria
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
January 16, 2024
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
Media
DUR Criteria
Resource List - New or Revised Criteria
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
2023
October 17, 2023
DUR Criteria
Old Business
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
Media
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
July 18, 2023
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
April 18, 2023
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
or
follow this link to go back to the first header